ARCHIVES

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

This article is from The Cancer Letter archive.

Vol. 23 No. 7 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

Cooperative Groups Other Investigators To Get Interferon When Available; DCT Recompetitions Okayed

April 4, 1980

Medenica’s Claims Of Association On CV, Brochures, Challenged By Some Institutions

April 30, 1993

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

November 16, 2001

IDMC Halts Mekinist-Tafinlar Trial Early Due to OS Benefit; Recommends Crossover

July 25, 2014

Waksal To Pay Back $800,000 In Profits From Stock Sales

March 14, 2003

ODAC Calls For Tougher Standards For Accelerated Approval In Oncology

February 11, 2011